Back
Royalty Pharma PLC Vs. Amphastar Pharmaceuticals Industry Stock Comparison
Sell
38
RPRX
Royalty Pharma PLC
Last Price:
27.86
Seasonality Move:
-2.02%
Buy
69
AMPH
Amphastar Pharmaceuticals
Last Price:
42.70
Seasonality Move:
7.25%
Sell
38
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $28.21. The Score for RPRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $42.44. The Score for AMPH is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $28.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $42.44
The current trend is relatively stagnant and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 47.19 | Sell |
Chaikin Money Flow: | -466302 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.79 - 28.45) | Buy |
Bollinger Bands (100): | (27.98 - 30.06) | Sell |
AMPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 52.11 | Buy |
Chaikin Money Flow: | 331989 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.21 - 42.43) | Buy |
Bollinger Bands (100): | (41.6 - 56.14) | Sell |
RPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.18 | Buy |
20-day SMA: | 28.11 | Buy |
50-day SMA: | 29.01 | Sell |
200-day SMA: | 28.6 | Sell |
8-day EMA: | 28.18 | Buy |
20-day EMA: | 28.28 | Sell |
50-day EMA: | 28.68 | Sell |
200-day EMA: | 29.65 | Sell |
AMPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.31 | Buy |
20-day SMA: | 41.58 | Buy |
50-day SMA: | 42.33 | Buy |
200-day SMA: | 50.43 | Sell |
8-day EMA: | 42.13 | Buy |
20-day EMA: | 41.97 | Buy |
50-day EMA: | 43.53 | Sell |
200-day EMA: | 47.5 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.09 per share, an increase this year of $0.35 per share, and an increase next year of $0.39 per share.
Royalty Pharma PLC Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amphastar Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |